Navigation Links
Common plants can eliminate indoor air pollutants
Date:11/4/2009

ATHENS, GAAir quality in homes, offices, and other indoor spaces is becoming a major health concern, particularly in developed countries where people often spend more than 90% of their time indoors. Surprisingly, indoor air has been reported to be as much as 12 times more polluted than outdoor air in some areas. Indoor air pollutants emanate from paints, varnishes, adhesives, furnishings, clothing, solvents, building materials, and even tap water. A long list of volatile organic compounds, or VOCs [including benzene, xylene, hexane, heptane, octane, decane, trichloroethylene (TCE), and methylene chloride], have been shown to cause illnesses in people who are exposed to the compounds in indoor spaces. Acute illnesses like asthma and nausea and chronic diseases including cancer, neurologic, reproductive, developmental, and respiratory disorders are all linked to exposure to VOCs. Harmful indoor pollutants represent a serious health problem that is responsible for more than 1.6 million deaths each year, according to a 2002 World Health Organization report.

Stanley J. Kays, Department of Horticulture, University of Georgia, was the lead researcher of a study published in HortScience that tested ornamental indoor plants for their ability to remove harmful VOCs from indoor air. According to Kays, some indoor plants have the ability to effectively remove harmful VOCs from the air, and not only have the ability to improve our physical health, but also have been shown to enhance our psychological health. Adding these plants to indoor spaces can reduce stress, increase task performance, and reduce symptoms of ill health.

The ability of plants to remove VOCs is called "phytoremediation". To better understand the phytoremediation capacity of ornamental plants, the research team tested 28 common indoor ornamentals for their ability to remove five volatile indoor pollutants. "The VOCs tested in this study can adversely affect indoor air quality
'/>"/>

Contact: Michael W. Neff
mwneff@ashs.org
703-836-4606
American Society for Horticultural Science
Source:Eurekalert  

0

GOOD

Page: 1 2

Related medicine news :

1. UK junior doctors gaining less experience of common procedures
2. New insights into common knee injuries
3. High and mighty: first common height gene identified by researchers behind obesity gene finding
4. Figure Skater Peggy Fleming, HealthSaver Says: Take Pains For Back Strains, 2nd Most Common Doctor Complaint
5. Exelixis Commences Public Offering of Common Stock
6. Common misdiagnosis: most women believe they have a yeast infection when they dont
7. Business Executives Discuss National Health Care Reform at Conference Sponsored by The Century Foundation, with Support from The Commonwealth Fund, and AARP
8. New Expert Report Dispels Common Myths About Aspartame
9. Common Foot Myths Trip Us Up
10. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
11. Allergy-Induced Asthma More Common in Affluent Countries
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Common plants can eliminate indoor air pollutants
Common plants can eliminate indoor air pollutants
(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2
...CFS) has been associated with altered amounts of s...oencephalograph (EEG) activity and impaired sleep... journal SLEEP finds that CFS is also associated w...Roseanna Armitage, PhD, and colleagues at the Univ...
... not pose a risk of cancer; a Danish study conduct... has shown. Danish medical records were a... cancer, or brain cancer among the utility workers...bstantial evidence linking exposure to electro mag...
... have died in a hospital here in the month of Apri...ed from his post for not informing the state gove...s, however, put the number of infant deaths at the...sts conducted at the microbiology department of th...
...eed lift one out of depression. But its potential ...ognized . Now the U.S. Food and Drug Admin...tidepressant medications update the existing black...ring initial treatment, generally the first one to...
...Dakota is now infusing roasted sunflower seeds w...energy drinks , to provide players and other peopl... The product, which has been under developmen...e, lysine and ginseng are added. The 3.5-ounc...
...rchers, diabetes is fast becoming a common reason ...he Reproductive Medicine Research Group at Queen's... semen samples of 57 men who were diagnosed with D...such samples it was seen that diabetes brought abo...
Other Medicine News:Health News:Government Expels Superintendent for Not Informing Newborn Deaths 2Health News:FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too 2Health News:FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too 3Health News:Caffeinated Sunflower Seeds To Hit The Market 2Health News:Fertility Rates Felled By Diabetes 2
(Date:12/4/2009)MORRISTOWN, N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2US Oncology Reports Second Quarter Operating Results 53858 1US Oncology Reports Second Quarter Operating Results 53858 2US Oncology Reports Second Quarter Operating Results 53858 3US Oncology Reports Second Quarter Operating Results 53858 4US Oncology Reports Second Quarter Operating Results 53858 5US Oncology Reports Second Quarter Operating Results 53858 6US Oncology Reports Second Quarter Operating Results 53858 7US Oncology Reports Second Quarter Operating Results 53858 8US Oncology Reports Second Quarter Operating Results 53858 9US Oncology Reports Second Quarter Operating Results 53858 10US Oncology Reports Second Quarter Operating Results 53858 11US Oncology Reports Second Quarter Operating Results 53858 12US Oncology Reports Second Quarter Operating Results 53858 13US Oncology Reports Second Quarter Operating Results 53858 14US Oncology Reports Second Quarter Operating Results 53858 15US Oncology Reports Second Quarter Operating Results 53858 16US Oncology Reports Second Quarter Operating Results 53858 17US Oncology Reports Second Quarter Operating Results 53858 18US Oncology Reports Second Quarter Operating Results 53858 19US Oncology Reports Second Quarter Operating Results 53858 20US Oncology Reports Second Quarter Operating Results 53858 21US Oncology Reports Second Quarter Operating Results 53858 22US Oncology Reports Second Quarter Operating Results 53858 23US Oncology Reports Second Quarter Operating Results 53858 24US Oncology Reports Second Quarter Operating Results 53858 25Efforts by Blue Cross Blue Shield of Michigan Physician Practices Help Michigan Become a Leading Adopter of E prescribing 53856 1Efforts by Blue Cross Blue Shield of Michigan Physician Practices Help Michigan Become a Leading Adopter of E prescribing 53856 2Efforts by Blue Cross Blue Shield of Michigan Physician Practices Help Michigan Become a Leading Adopter of E prescribing 53856 3BD Adds Surveillance Capability to Infectious Disease Portfolio 53851 1BD Adds Surveillance Capability to Infectious Disease Portfolio 53851 2BD Adds Surveillance Capability to Infectious Disease Portfolio 53851 3
...o, a division of Merck KGaA, Darmstadt, Germany, t... develop and commercialize Ambrx,s ARX424 preclini...e sclerosis. ARX424 was created by Ambrx through ...ation technology, ReCODE(TM). , , This second col...vious agreement announced in 2007 to develop ARX20...
...ceuticals, Inc. (Nasdaq: MAPP ) announced today ...nit Dose Budesonide (UDB) for the potential,treatm...d that the clinical,trial did not meet its co-prim...es from baseline in nighttime and daytime composit..., when compared with placebo. Median,nebulization...
Other Medicine Technology:Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance 2Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance 3MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints 2MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints 3
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: